Science & Enterprise subscription

Follow us on Twitter

  • I just published Get Ready for Biological Programming, on Medium https://t.co/DGTKC7c4t0 Writing code with cells and genes.
    about 21 hours ago
  • The Pew Research Center last month reported results of surveys about mobile phone use, conducted in 11 emerging eco… https://t.co/EEmV2FmKas
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Mobile Phones in Emerging Economies https://t.co/MXoyQkhwIu #Science #Business
    about 2 days ago
  • Thank you @SciSeeker ... that's very kind. Where can I find a Science Seeker logo I can put on our site, to indicat… https://t.co/kXVMa32BHZ
    about 3 days ago
  • A biomedical engineering team devised techniques using a gel to produce more engineered T-cells, which in lab mice… https://t.co/d9GwEsAjxo
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

MIT Spins-Off 32 Start-Ups in 2018

Lesley Millar-Nicholson

Research done at Massachusetts Institute of Technology in 2018 led to creation of 32 new start-up enterprises as well as hundreds of licenses and patents. . . . → Read More: MIT Spins-Off 32 Start-Ups in 2018

UC-Berkeley to Get New Crispr Patent

U.S. Patent and Trademark Office

University of California in Berkeley will soon receive a new patent for its development of the genome editing process known as Crispr, the latest round in a years-long dispute. . . . → Read More: UC-Berkeley to Get New Crispr Patent

Insulin Delivered by Capsule, That’s the Good News

Diabetes word cloud

Before we start celebrating the end of injections, we need to deal with a more basic problem facing people with diabetes, namely the rapidly rising cost of insulin. . . . → Read More: Insulin Delivered by Capsule, That’s the Good News

Company to Stop Cancer Spread, Relapse Raises $60.8M

Cancer magnified

A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing. . . . → Read More: Company to Stop Cancer Spread, Relapse Raises $60.8M

Natural Enemy Shown Effective Against Staph Bacteria

MRSA bacteria

A clinical trial shows adding a treatment for drug-resistant infections based on the bacteria’s natural enemies kills more Staphylococcus aureus bacteria than standard antibiotics alone. . . . → Read More: Natural Enemy Shown Effective Against Staph Bacteria

Start-Ups Saying No Thanks to Venture Capital

Calculator cash calendar

Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money. . . . → Read More: Start-Ups Saying No Thanks to Venture Capital

Spin-Off Gains Seed Funds for Non-Opioid Pain Drug

Molly Shoichet

A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial. . . . → Read More: Spin-Off Gains Seed Funds for Non-Opioid Pain Drug

Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal

Neurons illustration

Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain. . . . → Read More: Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

Companies Partner on High-Resolution 3-D Tissue Printer

Holograph-X bioprinter

Two developers of tissue engineering technologies are building a three-dimensional bioprinter that produces high resolution, finely structured human tissue, including tiny blood vessels. . . . → Read More: Companies Partner on High-Resolution 3-D Tissue Printer